
AASCRM Webinar

In order to promote in-depth exchanges on stem cell research in Asia, the Asian Alliance for Stem Cells and Regenerative Medicine (AASCRM) will launch a monthly brand event - the "AASCRM Webinar" series of online academic lectures in 2025, which will continue in 2026.
This series is jointly created by the stem cell societies of China, Japan, South Korea, New Zealand and Australia. Once a month, this series brings together cutting-edge scholars from various countries to share the latest breakthroughs in the field of stem cells and regenerative medicine.
The tenth lecture of the 2026 series of events is hosted by Singapore and co-organized by Japan manage, Will be on October 13 (Tuesday) 11:00am–12:30am (Beijing time) Held online. We sincerely invite you to gather in the cloud and participate in this academic exchange. This event uses Zoom online meetings. Free to attend , you need to register in advance to obtain the participation link.

kidney regeneration
Report 1
Title: Macrophage-kidney assembly: modeling the contribution of the microenvironment to renal pathophysiology
Reporter: Yun Xia, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore
Report 2
Title: Generation of urinary tract organoids from human pluripotent stem cells
Reporter: Minoru Takasato, RIKEN Life Function Research Center (BDR)

Participation Guide:

Meeting format: Zoom online meeting
2. Registration method: The conference is free to attend. But you need to register in advance . Please click on the link to complete registration:
https://zoom.us/meeting/register/Gmi5xq9HQlSMHwPhuVaKrQ#/registration
3. Instructions for participants: The meeting will use the Zoom platform. Please be sure to register at least two days in advance for review. After successful registration, the system will send an exclusive conference link to your email (please check your spam email if you do not receive it). Please do not record, copy or share the meeting content privately, and all information must be kept confidential. Violators will be dismissed and legal liability may be pursued. Thanks for your cooperation!